|
V.D. Makarova (1), M.R. Egiyan (1), E.A. Orlov (1), I Sun Cher (2), V.A. Dadaeva (3), A.Yu. Os’kova (1), E.S. Akarachkova (4), A.S. Orlova (1), E.V. Silina (1)
IMPORTANCE OF INCREASING AWARENESS OF CHILDREN AND ADOLESCENTS ABOUT RISK FACTORS AND THE main SYMPTOMS OF THE STROKE
|
№15 / 2017
|
|
O.Yu. Barysheva, I.M. Marusenko, N.N. Vezikova, A.A. Melentyeva
MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS
|
№s3-17 / 2017
|
|
S.V. Khokhlova, I.Ya. Bazaeva
OPTIMAL TACTICS OF ADJUVANT TREATMENT OF PATIENTS WITH ENDOMETRIAL CANCER
|
№8 / 2017
|
|
A.V. Pashentseva, A.F. Verbovoy
OSTEOPOROSIS IN MEN
|
№16 / 2016
|
|
D.V. Nebieridze (1), T.V. Kamyshova (1), A.A. Sarycheva (2)
EVALUATION OF FREQUENCY OF TARGET ORGAN DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION WHO APPLIED FOR AN OUTPATIENT APPOINTMENT WITH A DOCTOR FOR THE FIRST TIME
|
№9 / 2016
|
|
N.V. Chichasova
OSTEOARTHROSIS AND COMORBIDITY: PROBLEM OF CHOICE OF NSAIDS
|
№19 / 2015
|
|
K.A. Zakharov (1), K.G. Surkov (1), V.B. Vasilyuk (2), A.G. Sinenchenko (1), G.A. Volkov (1), A.A. Sukhoruk (3), E.V. Esaulenko (3)
THE EFFICACY OF USE OF THE DRUG NEOVIR FOR PREVENTING INFLUENZA AND ACUTE RESPIRATORY INFECTION MORBIDITY IN INDUCTRIAL COLLECTIVES
|
№11 / 2015
|
|
P.V. Seliverstov, E.M. Prikhodko, V.P. Dobritsa, V.G. Radchenko
SOME PROBLEMS OF DIAGNOSIS, TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE
|
№2 / 2015
|
|
A.A. Usanova, N.N. Guranova, I.Kh. Fazlova, T.A. Kunyaeva
INFLUENCE OF RISK FACTORS FOR CARDIOVASCULAR DISEASES ON THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN DRAFT AGE PERSONS ACCORDING TO THE DATA OF CARDIOLOGICAL UNIT OF THE SBHCI MR"MRCH"
|
№20 / 2014
|
|
V.V. Tsukanov, A.V. Vasyutin, Yu.L. Tonkikh, O.S. Amelchugova
THERAPY OF NONALCOHOLIC FATTY LIVER DISEASE. IS THERE A PLACE FOR HEPATOPROTECTORS?
|
№18 / 2014
|
|
D.V. Akimova
RISK FACTORS FOR OSTEOPOROSIS
|
№7 / 2014
|
|
N.A. Chernikova 1, M.B. Antsiferov 2
ROLE AND PLACE OF HYPOGLYCEMIA IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
Русский
